mammary epithelial cell supplement pack Search Results


94
ATCC pcs 600 040
Pcs 600 040, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc04769161-9-8-6?v=ATCC
Average 94 stars, based on 1 article reviews
pcs 600 040 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Lonza mammary epithelial growth medium (megm) from clonetics/lonza
Mammary Epithelial Growth Medium (Megm) From Clonetics/Lonza, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc07155769-151-44-50?v=Lonza
Average 90 stars, based on 1 article reviews
mammary epithelial growth medium (megm) from clonetics/lonza - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza megm medium
Megm Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/us08703712-241-7-9?v=Lonza
Average 90 stars, based on 1 article reviews
megm medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Celprogen Inc human breast epithelial cell culture serum free media
Human Breast Epithelial Cell Culture Serum Free Media, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc05797041-181-18-26?v=Celprogen+Inc
Average 90 stars, based on 1 article reviews
human breast epithelial cell culture serum free media - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Kurabo industries human primary mammary epithelial cells
Reprogramming of human MCF-10A mammary <t>epithelial</t> cells. (a) Experimental scheme for the reprogramming of MCF-10A cells. (b) Phase-contrast images and immunofluorescence images of iPS-like colonies from MCF-10A cells (iPSL-10A) and normal human iPSCs stained with antibodies against OCT4, SOX2, TRA-1-60 and Nanog. Scale bar, 500 µm. (c) Semiquantitative reverse transcriptase–PCR (RT–PCR) analysis of iPSC markers in iPSL-10A cell clones 1–4, normal human iPSCs and MCF-10A cells. SOX2 and OCT4 are endogenously derived. (d) Immunoblotting of the stem cell marker proteins in iPSL-10A cell clones 1–4, normal human iPSCs and MCF-10A cells. (e) DNA methylation ‘heat map’ of iPSL-10A cells. DNA methylation analysis was performed using an Illumina Human Methylation 27 Beads Chip (MBL) with genomic DNA extracted from iPSL-10A clones 1 and 2, normal human iPSCs and MCF-10A cells. The β-value was calculated by a quantitative measure of the DNA methylation levels at specific CpG islands. Average β-values were subjected to unsupervised hierarchical clustering based on the Manhattan distance and average linkage. (f) High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM PCR). Genomic DNA was prepared using phenol/chloroform extraction and subjected to LAM PCR. Amplicons were validated by sequencing. (g) Standard G-band chromosome analysis of MCF-10A and iPSL-10A cells. Arrows indicate identifiable aberrations common to both cell types.
Human Primary Mammary Epithelial Cells, supplied by Kurabo industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc04697746-302-0-8?v=Kurabo+industries
Average 90 stars, based on 1 article reviews
human primary mammary epithelial cells - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza human mammary epithelial cells (post-stasis; pshmec)
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
Human Mammary Epithelial Cells (Post Stasis; Pshmec), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc06525037-193-0-9?v=Lonza
Average 90 stars, based on 1 article reviews
human mammary epithelial cells (post-stasis; pshmec) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza human umbilical vein endothelial cells (huvecs
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
Human Umbilical Vein Endothelial Cells (Huvecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pm24582970-55-0-9?v=Lonza
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvecs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza megm singlequot kit supplement & growth factors
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
Megm Singlequot Kit Supplement & Growth Factors, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc02942739-78-10-18?v=Lonza
Average 90 stars, based on 1 article reviews
megm singlequot kit supplement & growth factors - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza bullet kit
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
Bullet Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc06727561-235-13-16?v=Lonza
Average 90 stars, based on 1 article reviews
bullet kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza epidermal growth factor (egf
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
Epidermal Growth Factor (Egf, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pmc07515519-211-23-28?v=Lonza
Average 90 stars, based on 1 article reviews
epidermal growth factor (egf - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
ATCC human mammary gland adenocarcinoma cell line mda mb 231
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
Human Mammary Gland Adenocarcinoma Cell Line Mda Mb 231, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pm40540027-51-0-7?v=ATCC
Average 99 stars, based on 1 article reviews
human mammary gland adenocarcinoma cell line mda mb 231 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC 4t1 mammary carcinoma cells
Leptin primes mammary <t>epithelial</t> cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).
4t1 Mammary Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mammary+epithelial+cell+supplement+pack/pm40541272-227-19-41?v=ATCC
Average 99 stars, based on 1 article reviews
4t1 mammary carcinoma cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

Image Search Results


Reprogramming of human MCF-10A mammary epithelial cells. (a) Experimental scheme for the reprogramming of MCF-10A cells. (b) Phase-contrast images and immunofluorescence images of iPS-like colonies from MCF-10A cells (iPSL-10A) and normal human iPSCs stained with antibodies against OCT4, SOX2, TRA-1-60 and Nanog. Scale bar, 500 µm. (c) Semiquantitative reverse transcriptase–PCR (RT–PCR) analysis of iPSC markers in iPSL-10A cell clones 1–4, normal human iPSCs and MCF-10A cells. SOX2 and OCT4 are endogenously derived. (d) Immunoblotting of the stem cell marker proteins in iPSL-10A cell clones 1–4, normal human iPSCs and MCF-10A cells. (e) DNA methylation ‘heat map’ of iPSL-10A cells. DNA methylation analysis was performed using an Illumina Human Methylation 27 Beads Chip (MBL) with genomic DNA extracted from iPSL-10A clones 1 and 2, normal human iPSCs and MCF-10A cells. The β-value was calculated by a quantitative measure of the DNA methylation levels at specific CpG islands. Average β-values were subjected to unsupervised hierarchical clustering based on the Manhattan distance and average linkage. (f) High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM PCR). Genomic DNA was prepared using phenol/chloroform extraction and subjected to LAM PCR. Amplicons were validated by sequencing. (g) Standard G-band chromosome analysis of MCF-10A and iPSL-10A cells. Arrows indicate identifiable aberrations common to both cell types.

Journal: Oncogene

Article Title: Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors

doi: 10.1038/onc.2012.614

Figure Lengend Snippet: Reprogramming of human MCF-10A mammary epithelial cells. (a) Experimental scheme for the reprogramming of MCF-10A cells. (b) Phase-contrast images and immunofluorescence images of iPS-like colonies from MCF-10A cells (iPSL-10A) and normal human iPSCs stained with antibodies against OCT4, SOX2, TRA-1-60 and Nanog. Scale bar, 500 µm. (c) Semiquantitative reverse transcriptase–PCR (RT–PCR) analysis of iPSC markers in iPSL-10A cell clones 1–4, normal human iPSCs and MCF-10A cells. SOX2 and OCT4 are endogenously derived. (d) Immunoblotting of the stem cell marker proteins in iPSL-10A cell clones 1–4, normal human iPSCs and MCF-10A cells. (e) DNA methylation ‘heat map’ of iPSL-10A cells. DNA methylation analysis was performed using an Illumina Human Methylation 27 Beads Chip (MBL) with genomic DNA extracted from iPSL-10A clones 1 and 2, normal human iPSCs and MCF-10A cells. The β-value was calculated by a quantitative measure of the DNA methylation levels at specific CpG islands. Average β-values were subjected to unsupervised hierarchical clustering based on the Manhattan distance and average linkage. (f) High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM PCR). Genomic DNA was prepared using phenol/chloroform extraction and subjected to LAM PCR. Amplicons were validated by sequencing. (g) Standard G-band chromosome analysis of MCF-10A and iPSL-10A cells. Arrows indicate identifiable aberrations common to both cell types.

Article Snippet: Human primary mammary epithelial cells were purchased from Kurabo Industrial (Osaka, Japan).

Techniques: Immunofluorescence, Staining, Reverse Transcription, Reverse Transcription Polymerase Chain Reaction, Clone Assay, Derivative Assay, Western Blot, Marker, DNA Methylation Assay, Methylation, Amplification, Extraction, Sequencing

Characterization of the CSC properties of iCSCL-10A clones. (a) Flow cytometric analysis of CD44 and CD24 expression in the MCF-10A, iCSCL-10A and MCF7 cell lines. The numbers indicate the percentage of each sub-population according to the CD44/CD24 expression profile. (b, c) Tumor sphere formation assays of MCF-10A-Ras, iCSCL-10A and MCF7 cell lines. Phase-contrast images of tumor spheres are shown (b). Values represent the mean ± s.e.m. (n=3, c). (d) Semiquantitative reverse transcriptase–PCR (RT–PCR) analysis of the expression of CSC- or epithelial-to-mesenchymal transition (EMT)-related genes. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was analyzed as a control. (e) Viability of MCF-10A-Ras, iCSCL-10A and MCF7 cell lines treated with various chemotherapeutic agents for 72 h by MTT assay. Values represent the mean ± s.e.m. (n=3). (f, g) iCSCL-10A and parental MCF-10A cells were treated with Juglone (5 µm) for 24 h and subjected to TUNEL (terminal deoxyribonucleotidyl transferase-mediated dUTP nick end-labeling) assay (f, brown color). TUNEL-positive cells were scored from triplicate independent experiments (g). Values represent the mean ± s.e.m. (n=3).

Journal: Oncogene

Article Title: Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors

doi: 10.1038/onc.2012.614

Figure Lengend Snippet: Characterization of the CSC properties of iCSCL-10A clones. (a) Flow cytometric analysis of CD44 and CD24 expression in the MCF-10A, iCSCL-10A and MCF7 cell lines. The numbers indicate the percentage of each sub-population according to the CD44/CD24 expression profile. (b, c) Tumor sphere formation assays of MCF-10A-Ras, iCSCL-10A and MCF7 cell lines. Phase-contrast images of tumor spheres are shown (b). Values represent the mean ± s.e.m. (n=3, c). (d) Semiquantitative reverse transcriptase–PCR (RT–PCR) analysis of the expression of CSC- or epithelial-to-mesenchymal transition (EMT)-related genes. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was analyzed as a control. (e) Viability of MCF-10A-Ras, iCSCL-10A and MCF7 cell lines treated with various chemotherapeutic agents for 72 h by MTT assay. Values represent the mean ± s.e.m. (n=3). (f, g) iCSCL-10A and parental MCF-10A cells were treated with Juglone (5 µm) for 24 h and subjected to TUNEL (terminal deoxyribonucleotidyl transferase-mediated dUTP nick end-labeling) assay (f, brown color). TUNEL-positive cells were scored from triplicate independent experiments (g). Values represent the mean ± s.e.m. (n=3).

Article Snippet: Human primary mammary epithelial cells were purchased from Kurabo Industrial (Osaka, Japan).

Techniques: Clone Assay, Expressing, Reverse Transcription, Reverse Transcription Polymerase Chain Reaction, Control, MTT Assay, TUNEL Assay, End Labeling

iCSCL-10A cells form hierarchically organized tumors in vivo. (a) Tumor-seeding ability of iCSCL-10A, MCF-10A-Ras parental MCF-10A cells and iPSC-EBD. The indicated numbers of each cell type were injected into immunocompromised mice. The tumor-initiation ability per injection was then monitored. (b) Hematoxylin and eosin (H&E) staining of primary tumor tissues. Scale bar, 500 µm. (c) Immunohistochemical analysis of primary tumor tissues derived from iCSCL-10A cells using antibodies targeting hCD34 (endothelial), smooth muscle actin (SMA; myoblastic), β3-tubulin (neural), cytokeratin (CAM5.2, epithelial), vimentin (mesenchymal) and osteopontin (osteoblastic). Scale bar, 500 µm. (d) Immunofluorescent analysis with antibodies targeting SOX2 and cytokeratin (AE1/AE3). Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Scale bar, 500 µm.

Journal: Oncogene

Article Title: Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors

doi: 10.1038/onc.2012.614

Figure Lengend Snippet: iCSCL-10A cells form hierarchically organized tumors in vivo. (a) Tumor-seeding ability of iCSCL-10A, MCF-10A-Ras parental MCF-10A cells and iPSC-EBD. The indicated numbers of each cell type were injected into immunocompromised mice. The tumor-initiation ability per injection was then monitored. (b) Hematoxylin and eosin (H&E) staining of primary tumor tissues. Scale bar, 500 µm. (c) Immunohistochemical analysis of primary tumor tissues derived from iCSCL-10A cells using antibodies targeting hCD34 (endothelial), smooth muscle actin (SMA; myoblastic), β3-tubulin (neural), cytokeratin (CAM5.2, epithelial), vimentin (mesenchymal) and osteopontin (osteoblastic). Scale bar, 500 µm. (d) Immunofluorescent analysis with antibodies targeting SOX2 and cytokeratin (AE1/AE3). Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Scale bar, 500 µm.

Article Snippet: Human primary mammary epithelial cells were purchased from Kurabo Industrial (Osaka, Japan).

Techniques: In Vivo, Injection, Staining, Immunohistochemical staining, Derivative Assay

Leptin primes mammary epithelial cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).

Journal: Oncogene

Article Title: Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland

doi: 10.1038/s41388-019-0687-8

Figure Lengend Snippet: Leptin primes mammary epithelial cells for proliferation. a Bright field micrographs of differentiated S1 acini treated for 72h with vehicle or leptin. Scale bar, 100 µm. b Representative confocal images and quantification of Ki67 staining in acini treated for 72h with vehicle, with leptin (100 ng/ml), with IGF-1 (0.1 µg/ml) and elevated insulin (500 ng/ml), or with the combination of the three factors. Scale bar, 20 µm. *, P < 0.05 and **, P < 0.01 (one-way ANOVA and Tukey's; n = 5). c Sizes (cross sections) of acini treated as in B. *, P < 0.05 (compared to all other treatments, one-way ANOVA and Fisher’s LSD, n = 3). d Apical localization of ZO-1 in acini treated as in B. **, P < 0.01, n.s., P > 0.05 (one-way ANOVA and Tukey's; n = 3). e Analysis of Ki67 in S1 acini after treatments with leptin and growth factors. Treatments were dissociated in time, as indicated in the schematic. Values were normalized to control (vehicle/vehicle). *, P < 0.05 (Kruskal-Wallis and Dunn’s, n = 4).

Article Snippet: Human mammary epithelial cells (post-stasis; psHMEC) were obtained from Lonza (Walkersville MD, USA) and cultured on Matrigel-coated surfaces with the supplier’s Epithelial Cell Medium for up to 5 passages.

Techniques: Staining, Control

Leptin leads to mitotic spindle misalignment. a Detection of ZO-1 and NuMA by immunofluorescence in polarized monolayers of S1 cells. Scale bar, 10 µm. b Mitotic spindle orientation in S1 cell monolayers treated with vehicle or leptin, as measured by confocal microscopy. Images on top represent maximal intensity projections whereas bottom images (a-d) are representative orthogonal views of the dual NuMA-DAPI staining. Angles between the two spindle poles (dashed lines) and the horizontal are quantified in the graph. **, P < 0.01 (unpaired t-test, n = 30 cells from two independent experiments). c Histology of mammary glands from mice with diet-induced obesity (DIO) and mice fed a control diet. Arrows indicate multilayered acini, defined as having ≥ 3 cell layers. d Correlation between apical polarization (Par3 score) and multilayering in the mammary epithelium from control and DIO mice. The exact P value (two-tailed Spearman test) was computed. The graphs represent mean ± SEM (B-E) or mean ± SD (G). e Schematic summarizing the effect of leptin on epithelial polarity and the functional consequences of polarity loss in the premalignant context.

Journal: Oncogene

Article Title: Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland

doi: 10.1038/s41388-019-0687-8

Figure Lengend Snippet: Leptin leads to mitotic spindle misalignment. a Detection of ZO-1 and NuMA by immunofluorescence in polarized monolayers of S1 cells. Scale bar, 10 µm. b Mitotic spindle orientation in S1 cell monolayers treated with vehicle or leptin, as measured by confocal microscopy. Images on top represent maximal intensity projections whereas bottom images (a-d) are representative orthogonal views of the dual NuMA-DAPI staining. Angles between the two spindle poles (dashed lines) and the horizontal are quantified in the graph. **, P < 0.01 (unpaired t-test, n = 30 cells from two independent experiments). c Histology of mammary glands from mice with diet-induced obesity (DIO) and mice fed a control diet. Arrows indicate multilayered acini, defined as having ≥ 3 cell layers. d Correlation between apical polarization (Par3 score) and multilayering in the mammary epithelium from control and DIO mice. The exact P value (two-tailed Spearman test) was computed. The graphs represent mean ± SEM (B-E) or mean ± SD (G). e Schematic summarizing the effect of leptin on epithelial polarity and the functional consequences of polarity loss in the premalignant context.

Article Snippet: Human mammary epithelial cells (post-stasis; psHMEC) were obtained from Lonza (Walkersville MD, USA) and cultured on Matrigel-coated surfaces with the supplier’s Epithelial Cell Medium for up to 5 passages.

Techniques: Immunofluorescence, Confocal Microscopy, Staining, Control, Two Tailed Test, Functional Assay

Apical polarity correlates with epithelial multilayering and adipokine imbalance in human breast tissue. a Confocal microscopy images of ZO-1 and Par3 immunostaining in frozen sections from normal breast tissue from two different patients (003 and 005). Cell nuclei were conterstained with DAPI. Scale bars, 50 µm. b Association between apical polarity scores derived from ZO-1 and Par3 staining. The Pearson correlation coefficient ( r s ) and P value are shown. Each dot on the graph represents one patient (n = 13). Error bars are SEM. c Association between apical polarity scores (ZO-1 or Par3) and the number of epithelial cell layers, determined based on DAPI images. Mean ± SEM are shown for each patient (n = 13) with r s and P values. d-e Apical polarity in normal breast tissue classified based on their relative leptin/adiponectin transcript abundance (high, above median; low, below median). Apical polarity (AP) loss was defined as patient score averages below the 25 th percentile (ZO-1 and Par3) or below the 50 th percentile (actin). AP results for ZO-1, Par3, and actin are shown individually ( d ) or in combination, by adding scores values of each marker ( e ; mean ± SD). #, P < 0.05 (two tailed Chi-square test); *, P < 0.05 (two tailed Mann-Whitney test).

Journal: Oncogene

Article Title: Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland

doi: 10.1038/s41388-019-0687-8

Figure Lengend Snippet: Apical polarity correlates with epithelial multilayering and adipokine imbalance in human breast tissue. a Confocal microscopy images of ZO-1 and Par3 immunostaining in frozen sections from normal breast tissue from two different patients (003 and 005). Cell nuclei were conterstained with DAPI. Scale bars, 50 µm. b Association between apical polarity scores derived from ZO-1 and Par3 staining. The Pearson correlation coefficient ( r s ) and P value are shown. Each dot on the graph represents one patient (n = 13). Error bars are SEM. c Association between apical polarity scores (ZO-1 or Par3) and the number of epithelial cell layers, determined based on DAPI images. Mean ± SEM are shown for each patient (n = 13) with r s and P values. d-e Apical polarity in normal breast tissue classified based on their relative leptin/adiponectin transcript abundance (high, above median; low, below median). Apical polarity (AP) loss was defined as patient score averages below the 25 th percentile (ZO-1 and Par3) or below the 50 th percentile (actin). AP results for ZO-1, Par3, and actin are shown individually ( d ) or in combination, by adding scores values of each marker ( e ; mean ± SD). #, P < 0.05 (two tailed Chi-square test); *, P < 0.05 (two tailed Mann-Whitney test).

Article Snippet: Human mammary epithelial cells (post-stasis; psHMEC) were obtained from Lonza (Walkersville MD, USA) and cultured on Matrigel-coated surfaces with the supplier’s Epithelial Cell Medium for up to 5 passages.

Techniques: Confocal Microscopy, Immunostaining, Derivative Assay, Staining, Marker, Two Tailed Test, MANN-WHITNEY